[HTML][HTML] Experimental human challenge infections can accelerate clinical malaria vaccine development

RW Sauerwein, M Roestenberg… - Nature Reviews …, 2011 - nature.com
Malaria is one of the most frequently occurring infectious diseases worldwide, with almost 1
million deaths and an estimated 243 million clinical cases annually. Several candidate …

Experimental infection of human volunteers

M Roestenberg, MA Hoogerwerf… - The Lancet Infectious …, 2018 - thelancet.com
Controlled human infection (CHI) trials, in which healthy volunteers are experimentally infected,
can accelerate the development of novel drugs and vaccines for infectious diseases of …

[HTML][HTML] A controlled human Schistosoma mansoni infection model to advance novel drugs, vaccines and diagnostics

…, M Yazdanbakhsh, LG Visser, M Roestenberg - Nature medicine, 2020 - nature.com
Schistosomiasis treatment relies on the use of a single drug, praziquantel, which is insufficient
to control transmission in highly endemic areas 1 . Novel medicines and vaccines are …

[HTML][HTML] Protection against a malaria challenge by sporozoite inoculation

M Roestenberg, M McCall, J Hopman… - … England Journal of …, 2009 - Mass Medical Soc
Background An effective vaccine for malaria is urgently needed. Naturally acquired
immunity to malaria develops slowly, and induction of protection in humans can be achieved …

[HTML][HTML] Longevity and Composition of Cellular Immune Responses Following Experimental Plasmodium falciparum Malaria Infection in Humans

AC Teirlinck, MBB McCall, M Roestenberg… - PLoS …, 2011 - journals.plos.org
Cellular responses to Plasmodium falciparum parasites, in particular interferon-gamma (IFNγ)
production, play an important role in anti-malarial immunity. However, clinical immunity to …

[HTML][HTML] Controlled human malaria infections by intradermal injection of cryopreserved Plasmodium falciparum sporozoites

M Roestenberg, EM Bijker, BKL Sim… - The American journal …, 2013 - ncbi.nlm.nih.gov
Controlled human malaria infection with sporozoites is a standardized and powerful tool for
evaluation of malaria vaccine and drug efficacy but so far only applied by exposure to bites …

[HTML][HTML] Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trial

…, KM Mullane, A Castagna, LYA Chai, M Roestenberg… - Jama, 2020 - jamanetwork.com
Importance Remdesivir demonstrated clinical benefit in a placebo-controlled trial in patients
with severe coronavirus disease 2019 (COVID-19), but its effect in patients with moderate …

Perspective on schistosomiasis drug discovery: highlights from a schistosomiasis drug discovery workshop at Wellcome Collection, London, September 2022

…, G Padalino, KD Read, M Roestenberg… - ACS infectious …, 2023 - ACS Publications
In September 2022, the Drug Discovery Unit at the University of Dundee, UK, organised an
international meeting at the Wellcome Collection in London to explore the current clinical …

Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study

M Roestenberg, AC Teirlinck, MBB McCall, K Teelen… - The Lancet, 2011 - thelancet.com
Background We have shown that immunity to infection with Plasmodium falciparum can be
induced experimentally in malaria-naive volunteers through immunisation by bites of infected …

[HTML][HTML] Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19

…, JJC de Vries, JJ Janse, M Roestenberg… - Nature …, 2022 - nature.com
Systemic immune cell dynamics during coronavirus disease 2019 (COVID-19) are extensively
documented, but these are less well studied in the (upper) respiratory tract, where severe …